World Health Organization

The World Health Organization is the directing and coordinating authority on international health within the United Nations system. Its constitution, drafted at the International Health Conference held in New York City in the summer of 1946, defines the organization's objective as the attainment by all peoples of the highest possible level of health, and it defines health in broad terms as a state of complete physical, mental, and social well-being, not merely the absence of disease or infirmity. This expansive definition has shaped the WHO mandate for more than seven decades and continues to guide its programs in primary care, maternal and child health, nutrition, mental health, and the social determinants of health.

Member states govern the organization through the World Health Assembly, which convenes in Geneva each May, and through an Executive Board of 34 members whose terms are staggered across three years. Day-to-day operations are carried out by the Secretariat, led by a Director-General elected to a five-year term. Authority is decentralized to an unusual degree for a United Nations agency. Each of the six regional offices operates as a semi-autonomous entity under its own regional director and regional committee, a structure that reflects the historical absorption of earlier regional health bodies, above all the Pan American Sanitary Bureau, into the new organization in 1948 and 1949.

The work of the WHO spans the full breadth of global health. It coordinates responses to disease outbreaks, from the 2014 Ebola epidemic in West Africa to the COVID-19 pandemic and successive mpox emergencies. It sets international standards through instruments such as the International Health Regulations and the Framework Convention on Tobacco Control. It supports national health systems with technical guidance, prequalification of medicines and vaccines, and the publication of influential normative documents, including the Essential Medicines List, the International Classification of Diseases, and evidence-based clinical guidelines. And it partners with other United Nations agencies, non-governmental organizations, and philanthropic institutions on long-running initiatives such as the Global Polio Eradication Initiative, the Expanded Programme on Immunization, and the Roll Back Malaria Partnership.

The organization has been shaped across its history by both striking achievements and significant controversies. It presided over the eradication of smallpox, a feat widely regarded as the greatest public health accomplishment of the twentieth century, and it has driven polio cases down by more than 99 percent worldwide. At the same time, its response to the 2009 H1N1 influenza pandemic, the 2014 Ebola epidemic, and the COVID-19 pandemic have all drawn critical scrutiny, producing a series of external evaluations and reform proposals that continue to influence its mandate, financing, and emergency powers.

The World Health Organization did not emerge from a vacuum. It inherited a rich set of institutions and practices that stretched back to the middle of the nineteenth century, when governments first recognized that infectious disease did not respect political frontiers. The first International Sanitary Conference convened in Paris in 1851 and sought to coordinate European responses to the repeated cholera epidemics that had swept out of the Ganges Delta along new steamship and railway routes. Over the following decades, a series of International Sanitary Conferences produced a sequence of sanitary conventions, the direct ancestors of the modern International Health Regulations, which harmonized national quarantine rules for cholera, plague, yellow fever, and other quarantinable diseases.

Two permanent international bodies grew out of this early cooperation. In the Americas, the International Sanitary Bureau was established in Washington, D.C. in 1902 by the twenty-one states of the Pan American Union, making it the oldest continuously operating international health body in the world. In Europe, the Rome Agreement of 1907 created the Office International d'Hygiène Publique, headquartered in Paris, which maintained an international list of quarantinable diseases and circulated outbreak information among participating governments. After the First World War, the League of Nations Health Organisation, founded in 1921 and also based in Geneva, added a programmatic dimension, supporting national public health services, carrying out epidemiological studies, and producing technical standards for vaccines and biological products.

The Second World War shattered this loose network. The League's Health Organisation effectively ceased operation, and wartime health programs were absorbed into the United Nations Relief and Rehabilitation Administration, which coordinated emergency medical relief across liberated Europe and Asia. When delegates gathered in San Francisco in 1945 to draft the Charter of the United Nations, a joint declaration by the Brazilian and Chinese delegations called for an international health conference to draft the constitution of a new and permanent world health organization. The International Health Conference met in New York City from June 19 to July 22, 1946, and on the final day, representatives of 61 states signed the Constitution of the World Health Organization.

The Constitution entered into force on April 7, 1948, the date on which the twenty-sixth member state deposited its instrument of ratification. That date is observed every year as World Health Day. The First World Health Assembly opened in Geneva on June 24, 1948, with Dr. Brock Chisholm of Canada elected as the organization's first Director-General. The Pan American Sanitary Bureau was integrated into the new structure as the Regional Office for the Americas in 1949, retaining a distinct identity as the Pan American Health Organization, and the Office International d'Hygiène Publique was formally dissolved after transferring its functions to the WHO.

The eradication of smallpox is widely considered the greatest single achievement in the history of public health and the defining accomplishment of the World Health Organization. Smallpox, caused by the variola virus, had killed an estimated 300 million people in the twentieth century alone before the intensified eradication campaign began. It produced a characteristic rash of pustules, killed roughly one in three of those infected, and left most survivors scarred or blind.

In 1959, the Twelfth World Health Assembly, acting on a Soviet proposal, passed a resolution setting smallpox eradication as a goal of the organization. Progress during the 1960s was uneven, and in 1967 the Intensified Smallpox Eradication Programme was launched under the leadership of the American epidemiologist D. A. Henderson at WHO headquarters in Geneva. The program replaced mass vaccination with a strategy of surveillance and containment. Teams of national and international health workers located every new case, ring-vaccinated contacts and entire villages, and traced chains of transmission until they died out.

The last naturally occurring case of variola major, the most severe form of the disease, was recorded in a three-year-old girl named Rahima Banu in Bangladesh in October 1975. The last naturally occurring case of variola minor, and the last natural case of smallpox of any kind, was recorded in Ali Maow Maalin, a hospital cook in Merca, Somalia, on October 26, 1977. A laboratory incident in Birmingham, England, in 1978 caused two additional cases and one death, but surveillance continued for two full years without detecting further transmission.

On May 8, 1980, the Thirty-third World Health Assembly formally certified that smallpox had been eradicated from the world, making it the only human disease deliberately driven to extinction. Two research stocks of the variola virus are retained today, one at the Centers for Disease Control and Prevention in Atlanta and one at the State Research Center of Virology and Biotechnology in Russia, under strict biosafety supervision and a continuing policy debate about whether they should be destroyed.

Encouraged by the success of smallpox eradication, the Forty-first World Health Assembly voted in May 1988 to set a goal of eradicating poliomyelitis by the year 2000. The Global Polio Eradication Initiative, known as GPEI, brought together the WHO, Rotary International, the United States Centers for Disease Control and Prevention, the United Nations Children's Fund, and later the Bill & Melinda Gates Foundation as lead partners.

When the initiative began in 1988, wild poliovirus paralyzed an estimated 350,000 children in more than 125 countries every year. By the mid-2020s, reported cases of wild poliovirus had fallen by more than 99 percent. Two of the three wild poliovirus serotypes, types 2 and 3, have been certified eradicated globally, leaving only wild type 1 in circulation. Endemic transmission of wild poliovirus is now confined to limited areas of Afghanistan and Pakistan, where conflict, population displacement, and vaccine hesitancy complicate immunization campaigns.

A persistent challenge for the program is circulating vaccine-derived poliovirus, often abbreviated cVDPV. The attenuated Sabin strains in oral polio vaccine can, in communities with low immunization coverage, regain virulence and transmissibility. Outbreaks of cVDPV have occurred across parts of Africa, the Middle East, and in 2022 and 2023 in the United Kingdom and the United States, driving a shift toward the novel oral polio vaccine type 2 and expanded use of inactivated polio vaccine.

The polio program is often described as the largest single public health effort in history, having vaccinated more than three billion children over the course of its existence. Its lessons, including the importance of routine immunization, sensitive surveillance, and community trust, have shaped every subsequent WHO disease eradication and elimination initiative, from guinea worm to measles to lymphatic filariasis.

The WHO's legal authority over cross-border disease spread is grounded in the International Health Regulations, a binding instrument adopted under Article 21 of the Constitution. The regulations trace their origin to the nineteenth-century International Sanitary Conventions and were last comprehensively revised in 2005 in response to the 2003 outbreak of severe acute respiratory syndrome (SARS). The 2005 revision expanded the scope from a narrow list of quarantinable diseases to any event that may constitute a public health emergency of international concern, and it required member states to develop core surveillance and response capacities.

A public health emergency of international concern, known by the acronym PHEIC, is the highest-level alarm the Director-General can raise under the regulations. It signals that an extraordinary event constitutes a public health risk to other states through international spread and potentially requires a coordinated international response. The declaration is made on the advice of a technical Emergency Committee and may include temporary recommendations on trade, travel, surveillance, and health measures at ports and airports. The full list of PHEICs declared under the revised regulations is short but significant.

The first PHEIC was declared for the 2009 H1N1 influenza pandemic. A second was declared in May 2014 over the resurgence of wild poliovirus. A third was declared in August 2014 for the West African Ebola epidemic, centered in Guinea, Liberia, and Sierra Leone, which ultimately caused more than 11,000 deaths. A fourth was declared in February 2016 for the Zika virus epidemic and its association with microcephaly and neurological disorders. A fifth was declared in July 2019 for the Ebola outbreak in the Democratic Republic of the Congo, and a sixth, the longest and most consequential to date, was declared on January 30, 2020 for COVID-19. Mpox was declared a PHEIC in July 2022 and, again, in August 2024 in response to the emergence of clade Ib strains in central Africa.

Alongside PHEIC declarations, the WHO operates a graded health emergencies programme, established in 2016 in the wake of the West African Ebola response. Grade 3 emergencies require a major, multi-country response coordinated by headquarters. The Global Outbreak Alert and Response Network, established in 2000, links national institutes and laboratories that deploy experts within days of a notification. For historical context, see the companion article on major pandemics in history, which places the modern WHO response within a longer arc of epidemic disease.

On December 31, 2019, the WHO Country Office in China was notified of a cluster of cases of pneumonia of unknown cause in Wuhan, in central China. On January 7, 2020, Chinese authorities identified a novel coronavirus later named SARS-CoV-2. The Director-General convened an Emergency Committee under the International Health Regulations on January 22, and after a second meeting on January 30, declared the outbreak a public health emergency of international concern. On March 11, 2020, characterizing the continued spread of the virus, the Director-General announced that COVID-19 could be characterized as a pandemic.

Over the following three years, COVID-19 generated the WHO's largest and most politically fraught emergency response. The Access to COVID-19 Tools (ACT) Accelerator was launched in April 2020, with a vaccines pillar known as COVAX co-led with Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI), and the United Nations Children's Fund. COVAX eventually delivered more than 2 billion doses of COVID-19 vaccine, the largest and most complex global vaccination effort in history, but it fell well short of its stated targets and was widely criticized for supply shortfalls relative to bilateral deals struck by wealthy countries.

The organization's handling of the pandemic has been subject to unusually detailed review. The Independent Panel for Pandemic Preparedness and Response (IPPPR), co-chaired by Helen Clark and Ellen Johnson Sirleaf, concluded in May 2021 that the February 2020 window between the PHEIC declaration and the widespread recognition of the pandemic was a missed opportunity and recommended stronger legal tools, more predictable financing, and an explicit warning system for pandemic threats. The International Health Regulations Review Committee recommended a series of amendments, many of which were adopted by the World Health Assembly in 2024.

Politics shaped the response at every stage. In April 2020, the Trump administration announced that the United States would freeze its contributions to the WHO and in July 2020 formally notified the United Nations Secretary-General of its intent to withdraw. The Biden administration reversed the withdrawal on its first day in office in January 2021 and reengaged with the organization. Tensions returned under a subsequent United States administration in 2025, adding further uncertainty to the WHO's financing. Negotiations on a new international pandemic agreement, initiated by the Assembly in December 2021, continued into 2025 and culminated in the adoption of the Pandemic Agreement by the Seventy-eighth World Health Assembly in May of that year.

The WHO is financed by two main streams of revenue. Assessed contributions, set by a formula tied to each member state's capacity to pay, represent a relatively stable base of funding and can be used flexibly by the Secretariat. Voluntary contributions, pledged by governments, philanthropic foundations, and multilateral partners, are usually earmarked for specific programs or regions. Since the 1990s, voluntary contributions have grown to account for roughly eighty percent of the organization's total income, and much of that voluntary money is heavily specified by its donors. The result is a budget in which assessed funds cover only a modest share of essential core functions such as normative work, outbreak response, and policy guidance.

The concentration of voluntary funding among a small number of donors has been a persistent source of criticism. The United States, the United Kingdom, Germany, the European Commission, the Bill & Melinda Gates Foundation, and the global vaccine alliance Gavi together have often provided well over half of voluntary contributions in recent years. Civil society groups, academic observers, and independent review panels have argued that this structure can bias priorities toward the interests of major donors and leave the organization vulnerable to the politics of individual contributors, as the COVID-19 episode made clear.

In response, successive reform efforts have sought to rebalance the financing model. The 2022 decision by the Assembly to progressively raise the share of the programme budget financed by assessed contributions to fifty percent by the 2030 to 2031 biennium is the most consequential change since the 1990s. Additional proposals under discussion include a replenishment-style mechanism similar to the Global Fund, stronger accountability for implementation of the International Health Regulations, and a dedicated pandemic emergency reserve funded by assessed or quasi-assessed contributions.

Beyond financing, the WHO has faced recurring criticism of its administrative efficiency and political neutrality. Internal investigations into sexual exploitation and abuse during the 2018 to 2020 Ebola response in the Democratic Republic of the Congo led to significant reforms in field operations and safeguarding. Observers in policy circles, including those at the Chatham House Centre on Global Health Security and the Center for Global Development, have called for clearer separation between the organization's normative and operational roles, and for greater independence of the Emergency Committees that advise the Director-General on PHEIC declarations. The long-running encyclopedic debates over the WHO's authority are part of a broader modern architecture of international cooperation that also includes the United Nations system as a whole and the post-World War II wave of institution-building that accompanied decolonization.

Detailed citations, data references, and institutional sources for all CountryReports content are listed on the Sources page. The following government agencies, intergovernmental bodies, academic research centers, and peer-reviewed journals are the primary authorities we rely on for content relating to the World Health Organization. Each link points to the institution's homepage or a relevant subsite.

WHO and Regional Offices

• World Health Organization (who.int) — The official site of the WHO, including the Constitution, Assembly resolutions, technical reports, and the International Health Regulations.
• Pan American Health Organization (PAHO) / AMRO — Regional office for the Americas, founded as the Pan American Sanitary Bureau in 1902 and integrated into the WHO in 1949.
• WHO Regional Office for Africa (AFRO) — Brazzaville-based regional office covering 47 African member states.
• WHO Regional Office for South-East Asia (SEARO) — Regional office in New Delhi covering 11 member states from Bangladesh to Timor-Leste.
• WHO Regional Office for Europe (EURO) — Copenhagen-based regional office covering 53 member states.
• WHO Regional Office for the Eastern Mediterranean (EMRO) — Cairo-based regional office for North Africa, the Middle East, and the Horn of Africa.
• WHO Regional Office for the Western Pacific (WPRO) — Manila-based regional office covering 37 member states and areas.
• WHO Institutional Repository for Information Sharing (IRIS) — Open repository of WHO publications, technical reports, and Assembly documents.
• Global Polio Eradication Initiative (GPEI) — WHO-led partnership with Rotary International, the US CDC, UNICEF, and the Gates Foundation.

United Nations and Intergovernmental Resources

• United Nations Dag Hammarskjöld Library — Treaty collections and documentary records relating to the WHO Constitution and its predecessor bodies.
• United Nations Treaty Collection — Authoritative text of the Constitution of the WHO and amending instruments.
• The Global Fund to Fight AIDS, Tuberculosis and Malaria — Long-running WHO partner on HIV, tuberculosis, and malaria financing.
• Gavi, the Vaccine Alliance — Co-lead of COVAX and long-running partner on global immunization programs.

Government Health Agencies

• United States Centers for Disease Control and Prevention (CDC) — Partner to the WHO in smallpox eradication, polio eradication, and pandemic surveillance through the Global Disease Detection network.
• CDC Morbidity and Mortality Weekly Report (MMWR) — Primary peer-reviewed publication of the US CDC; frequent coverage of WHO-coordinated outbreaks and PHEIC declarations.
• Africa Centres for Disease Control and Prevention — Specialized agency of the African Union, established 2017, that coordinates with the WHO Regional Office for Africa on continental health emergencies.

Peer-Reviewed Journals and Academic Research Centers

• New England Journal of Medicine (NEJM) — Frequently publishes original research on pandemics, vaccination, and WHO-coordinated clinical trials.
• Bulletin of the World Health Organization — The WHO's flagship peer-reviewed public health journal.
• Chatham House Global Health Programme — Research on global health security, pandemic preparedness, and the governance of the WHO.
• Center for Global Development — Global Health — Policy analysis on WHO financing, pandemic preparedness, and health system strengthening.
• Yale Institute for Global Health — Academic research center engaged with WHO normative work on health systems and equity.
• London School of Hygiene & Tropical Medicine — Research and training institution with long-standing links to the WHO on infectious disease epidemiology.
• Harvard T.H. Chan School of Public Health — Research center engaged on WHO-linked topics from health systems to pandemic preparedness.

If you notice an error or would like to suggest a correction, please use our contact page to get in touch.